Latest news from ATCC
ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance
ATCC receives CDC contract award to advance influenza surveillance through serology testing and assay development.
New Peer-reviewed Research Validates ATCC's Rigorous Standards for the HCMI Collection
Nature study validates ATCC HCMI organoids with up to 97.8% tumor fidelity for cancer research.
ATCC Wins Prestigious NIH Replication Prize for Advancing Reproducibility in Virus Research
ATCC recognized by NIH for groundbreaking work in improving reproducibility and reliability in critical virus research.
ATCC and Broad Institute Engineer New Cancer Models to Decode Resistance to Targeted Therapy
ATCC and the Broad Institute collaborated to develop CRISPR-engineered drug-resistant isogenic cell lines that replicate clinically observed resistance mechanisms to targeted therapies.